Twice-Yearly Depemokimab Delivers Clinically Meaningful Improvements in Patients With CRSwNP With Features of T2 inflammation and Disease Recurrence Following Surgery: Post Hoc Pooled Analysis of ANCHOR-1/-2

Journal of Allergy and Clinical Immunology 2026

View at publisher
Authors: Joseph K. Han, Stella Lee, Zachary M. Soler, Ahmad Sedaghat, Richard Follows, Christel Wilkinson, Justin Kwiatek, Peter Howarth, Martin Y. Desrosiers
DOI: 10.1016/j.jaci.2025.12.973
Cited by: 0

Fields of Study & Subjects

Sinusitis and nasal conditions Asthma and respiratory diseases Allergic Rhinitis and Sensitization

Publication details

Journal / source
Journal of Allergy and Clinical Immunology
Volume
157
Issue
2
Pages
AB434–AB434
Publication date
1 February 2026
Language
EN